Myasthenia gravis: open trials in Sweden

• NCT04951622

  A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  Trial Treatment · Phase 3 · Janssen Research & Development, LLC

  Karolinska University Hospital, Solna

  Registry updated 2026-11-05

• NCT06463587

  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  Trial Treatment · Phase 3 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

  Danderyds Sjukhus AB, Danderyd · Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg · Region Vaermland, Karlstad

  Registry updated 2026-10-21

• 2024-515627-10-00

  A double-blind, randomised, placebo-controlled, first-in-human (FIH) Phase I/IIa, multi-centre trial to assess safety, tolerability, and immune response of single and multiple ascending doses of TOL2 (Immune Tolerising Agent) in patients with generalised myasthenia gravis

  Trial Treatment · Phase 1/2 · Bonsai Biotherapeutics AB

  Karolinska University Hospital, Huddinge

  Registry updated 2026-09-09

All Myasthenia gravis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error